|
Canada Approves Breo Ellipta for Adults With Asthma
Medscape Canadian regulators have approved the dry powder combination of fluticasone furoate and vilanterol (Breo Ellipta, GlaxoSmithKline/Theravance) for once-a-day treatment of asthma in adults with reversible obstructive airways disease, GlaxoSmithKline … |
View full post on asthma – Google News